GlassScriptPhysician profile
Nicole S Tully
NPI 1437337813
$3,250.97
in general payments reported to CMS, 2019-2025
37 companies · $1,467 in 2025
The $1,467 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $106 · 2021: $252 · 2022: $282 · 2023: $464 · 2024: $360 · 2025: $1,467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,278 · Food and Beverage: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,278.00 |
| Food and Beverage | $1,012.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,352.47 | 2019-2025 | |
| Abbvie INC. | $434.15 | 2019-2024 | Synthroid, Lo Loestrin Fe, Orilissa |
| Evofem Biosciences, INC. | $136.12 | 2021-2025 | Phexxi, Solosec, Phexx |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2023 | Zeposia |
| Pfizer INC. | $120.03 | 2023-2024 | |
| Lilly USA, LLC | $115.16 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $83.86 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $68.39 | 2021-2025 | |
| Exact Sciences Corporation | $67.21 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Avion Pharmaceuticals | $66.66 | 2019-2021 | |
| Bausch Health US, LLC | $60.03 | 2022-2025 | Aplenzin |
| Agile Therapeutics, INC. | $56.86 | 2021-2023 | Twirla |
| Merck Sharp & Dohme LLC | $51.25 | 2019-2024 | Gardasil 9, Gardasil |
| Lupin INC. | $50.87 | 2019-2020 | |
| Therapeuticsmd, INC. | $45.58 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $44.83 | 2025 | Rybelsus, Ozempic |
| Takeda Pharmaceuticals U.S.A., INC. | $35.91 | 2019-2024 | Trintellix |
| Glaxosmithkline, LLC. | $31.86 | 2022-2023 | Arexvy |
| Scynexis, INC. | $27.81 | 2021-2022 | |
| Eisai INC. | $23.80 | 2019 | |
| Avanos Medical | $22.58 | 2019 | |
| Axsome Therapeutics, INC. | $17.75 | 2022 | |
| Currax Pharmaceuticals LLC | $16.83 | 2023 | Contrave |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.70 | 2022 | |
| Sumitomo Pharma America, INC. | $16.00 | 2023 | Myfembree |
| Medicem INC. | $15.23 | 2020 | |
| Sage Therapeutics, LLC | $15.00 | 2019 | |
| Shire North American Group INC | $14.21 | 2019 | |
| Duchesnay USA Incorporated | $14.20 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.00 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $13.80 | 2019 | |
| Amryt Pharma Holdings LTD | $13.41 | 2023 | Mycapssa |
| Chiesi USA, INC. | $13.17 | 2024 | Mycapssa |
| Organon LLC | $13.15 | 2021 | |
| Allergan, INC. | $12.97 | 2019 | |
| Coopersurgical, INC. | $12.12 | 2019 | |
| Celularity INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Tully listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.